Quotes Celldex Therapeutics, Inc. London S.E.
Stocks
0HUU
US15117B2025
Biotechnology & Medical Research
|
Delayed
London S.E.
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
Stock exchange
London S.E.
0HUU - $
-.--%
0
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| CLDX | 39.12USD | -3.31% | 16.62M $ | ||
CBOE
| CLDX | 39.13USD | -3.18% | 537K $ | |
|
Tradegate
| TCE2 | 33.76EUR | -2.79% | 5.06K € | |
|
Börse Stuttgart
| TCE2 | 33.82EUR | -2.79% | 2.77K € | |
|
Deutsche Boerse AG
| TCE2 | 34.21EUR | -0.15% | 0 € | |
|
Berne S.E.
| TCE1 | 32.46CHF | -0.49% | 0 CHF | |
|
Boerse Muenchen
| TCE2 | 33.95EUR | -2.72% | 0 € |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
3,072,075,291
Net sales (USD)
1,545,000
Free-Float
99.73 %
Free-Float capitalization (USD)
3,063,759,826
Indicators
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 3.07B | |
| -0.78% | -1.42% | +2.49% | +22.78% | 50.47B | |
| -6.00% | -0.75% | +442.41% | +544.39% | 44.56B | |
| -0.24% | +0.74% | +38.69% | +18.02% | 43.08B | |
| -1.55% | -2.07% | +23.08% | +81.47% | 41.7B | |
| -0.31% | -0.83% | +16.15% | +51.42% | 33.21B | |
| -1.79% | -3.24% | +27.00% | +129.56% | 16.77B | |
| -0.58% | -2.12% | - | - | 16.28B | |
| -0.88% | -0.66% | +11.60% | +27.75% | 14.58B | |
| -1.66% | -1.25% | +78.59% | +46.66% | 13.92B | |
| Average | -1.53% | -1.06% | +80.00% | +115.26% | 27.76B | |
| Weighted average by Cap. | -1.70% | -1.06% | +95.71% | +133.63% |
Historical Quotes: Celldex Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- CLDX Stock
- 0HUU Stock
- Quotes Celldex Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
